Correction to: Scientific Reports https://doi.org/10.1038/s41598-021-03675-0, published online 13 January 2022
The original version of this Article contained an error in Figure 7 where a preliminary rendition was published. The original Figure 7 and accompanying legend appear below.
SARS-CoV-2 S pseudotyped virus neutralization assay. (A) Scheme of the assay. HEK-293T cells transfected with ACE2 and TMPRSS2 protease were transduced with a SARS-CoV-2 S pseudotyped lentivirus carrying a GFP-encoding mRNA in the presence of different dilutions of mouse sera. Forty eight hours later, cells were observed under the microscope. Created with BioRender.com. (B) The number of GFP positive cells for each serial dilution was determined. The serum antibody dilution causing a 50% reduction of GFP positive cells (IC50) compared to control “virus only” treated cells was calculated using Graphpad Prism. PreIS corresponds to the preimmune sera.
The original Article has been corrected.
Author information
Authors and Affiliations
Consortia
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Argentinian AntiCovid Consortium. Author Correction: Covalent coupling of Spike’s receptor binding ___domain to a multimeric carrier produces a high immune response against SARS-CoV-2. Sci Rep 12, 1645 (2022). https://doi.org/10.1038/s41598-022-05984-4
Published:
DOI: https://doi.org/10.1038/s41598-022-05984-4
